医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

DSG to Attend Phar-East Conference in Suntec Singapore

2018年02月19日 PM03:00
このエントリーをはてなブックマークに追加


 

MALVERN, Pa.

DSG, Inc., a leader in eClinical software and services to the life science industry will be exhibiting at the Phar-East – Asia’s Pharma & Biotech Conference. The conference is set to take place February 28th to March 2nd at the Suntec Signore Convention & Exhibition Centre, in Suntec City Singapore.

Revamped and revitalized from Biopharma Asia Convention, Phar-East will be exploring 11 of the most exciting pharma areas in Asia: immunotherapy, vaccines, precision medicine, cell & gene therapy, biodata, orphan drugs, partnering, commercialization & market access, antibodies, biosimilars and biotech innovations. In the past, the event has drawn over 22,000 attendees over its first 9 years from all over the world. As Asia’s global life sciences portfolio and biotech hubs continue to grow, Phar East anticipates showcasing the very best in Asian pharma.

“This is our first year attending the Phar-East conference; I look forward to educating attendee’s on our robust software and give a better understanding of what separates us from our competitors,” said Al Campbell, vice president, strategic alliances and director, business development.

DSG invites attendees to meet with Al Campbell, and Ricky Brohmer, vice president of Asia operations, who will be available at booth G08 to demonstrate our eCaselink™ EDC software, and its complete line of integrated solutions.

To request a meeting or find upcoming events and conferences DSG will be attending, please visit: http://dsg-us.com/dsg-events.html.

About DSG

DSG is a founder of the eClinical industry and through its innovative technology helped shape the current eClinical landscape. Its solutions support the development of life saving drugs and therapies and DSG was one of the first companies to deploy proprietary eClinical products. DSG’s suite of award-winning solutions includes its flagship eCaseLink™ EDC, Risk-Based Monitoring, eSource, ePRO, IRT Randomization and Trial Supply Management, Drug Safety System, and CTMS. Founded in 1992, the company is proud to be recognized as the first provider of a fully integrated EDC and IRT Randomization and Clinical Supply System with the SCDM Data Driven Innovation Award. For more information, please visit www.dsg-us.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180218005001/en/

CONTACT

DSG, Inc.
Glenn R. Boyet, +1 484-913-2132
gboyet@dsg-us.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Scientist.comがインク誌から「米国内で最も急成長中の非公開企業」のトップ10に指名される
  • Urban Drinking Water Challenge 2018 Announces Winners from USA, India and Bangladesh
  • CANbridge Life Sciences Receives Approval to Commence CAN017 Ib/III Trial in Esophageal Squamous Cell Cancer (ESCC) In China
  • AVEO Announces Acceptance of CANbridge Investigational New Drug Application for CAN017 (AV-203) Trial in Esophageal Squamous Cell Cancer (ESCC) in China
  • STAAR Surgical and Shinjuku LASIK Clinic in Japan Announce Strategic Cooperation Agreement